SCHEMBL31430633

SCHEMBL31430633

CC1(C)O[C@H]2[C@H](c3ccc4c(N)ncnn34)O[C@](C#N)(CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)[C@H]2O1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.33
▸ SMYD2 Q9NRG4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19779082 0.90 POLRMT (0.34) POLRMT
SCHEMBL25386429 0.83 POLRMT (0.36) POLRMT
SCHEMBL25763012 0.83 POLRMT (0.34) POLRMT
SCHEMBL25388179 0.82 POLRMT (0.36) POLRMT
SCHEMBL25244021 0.82 POLRMT (0.36) POLRMT
SCHEMBL25388205 0.82 POLRMT (0.38) POLRMT
SCHEMBL25387181 0.82 POLRMT (0.35) POLRMT
SCHEMBL25386049 0.81 POLRMT (0.35) POLRMT
SCHEMBL25385737 0.81 POLRMT (0.35) POLRMT
SCHEMBL25393958 0.81 POLRMT (0.37) POLRMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090537-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2025-03-20 — — US disclosed
WO-2025049699-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2025-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250090537-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME EIF2AK2, MAVS, ZC3HAV1 POLRMT 13/4885SMYD2 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback